
Bladex is executing a capital-light, fee-driven strategy, supporting mid-teens ROE and attractive risk-adjusted returns for Latin America-focused investors. BLX's shares trade at 1.33x common book value and 8.5x forward earnings, with a ~5% dividend yield and a base-case 12–18 month total return of 20–27%. Loan growth remains robust (+20% y/y), but NIM is compressing; management targets 2.2–2.3% NIM and a 16–17% adjusted ROE by 2030.










